Miami Valley Hospital

Miami Valley Hospital was paid $159.26M by Medicaid between Jan 2018 and Dec 2024, across 575 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.

33Billing provider infoMIAMI VALLEY HOSPITAL
DAYTON, OH 45409

33aNPI1073688354assigned 11/21/2006

33bProvider typeAir Ambulance

28Total paid$159.26M

24GClaims3,581,941

24DCodes billed575

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Air Ambulance providers in Ohio

Rank by total paid#1 of 11

Median peer was paid$1.90M

This provider vs. median84×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	213,155	$9.48M
2019	257,055	$11.15M
2020	217,557	$12.60M
2021	251,183	$12.88M
2022	367,070	$15.67M
2023	1,425,601	$58.08M
2024incomplete	850,320	$39.40M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	175,059	149,104	$22.41M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	176,460	156,332	$20.45M
96361	Intravenous infusion, hydration; each additional hour	12%	64,729	43,626	$18.74M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.8%	75,674	62,483	$10.91M
J2350	Injection, ocrelizumab, 1 mg	6.7%	498	325	$10.61M
70450	Computed tomography, head or brain; without contrast material	3.3%	23,106	16,881	$5.27M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.5%	43,148	33,038	$4.03M
J9271	Injection, pembrolizumab, 1 mg	2.5%	531	289	$3.94M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	2.4%	32,990	25,889	$3.74M
G0378	Hospital observation service, per hour	2.3%	60,569	20,872	$3.67M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.1%	17,360	12,152	$3.32M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.0%	48,389	15,907	$3.26M

563 more codes

A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	2.0%	2,190	$3.19M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.9%	32,518	$3.07M
59025	Fetal non-stress test	1.6%	17,687	$2.56M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	17,192	$1.85M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	1.1%	20,714	$1.76M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.0%	8,894	$1.60M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,866	$1.47M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	8,730	$1.43M
A0434	Specialty care transport (sct)	<1%	8,099	$1.25M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	9,546	$1.13M
80048	Basic metabolic panel (calcium, ionized)	<1%	175,347	$1.11M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,403	$1.02M
67311		<1%	562	$965K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,720	$913K
47562		<1%	450	$806K
90791	Psychiatric diagnostic evaluation	<1%	4,352	$758K
J2323	Injection, natalizumab, 1 mg	<1%	144	$742K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	3,335	$648K
70496		<1%	2,937	$603K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,800	$601K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,263	$600K
76801		<1%	3,683	$493K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	787	$485K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	5,303	$450K
58661		<1%	247	$439K
76830	Ultrasound, transvaginal	<1%	5,266	$437K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	16,031	$426K
A0436	Rotary wing air mileage, per statute mile	<1%	2,125	$402K
A0425	Ground mileage, per statute mile	<1%	8,170	$392K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	16,859	$372K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	753	$341K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,612	$322K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,877	$317K
93970		<1%	2,831	$316K
70491		<1%	1,313	$315K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,021	$291K
78815	Positron emission tomography (PET) for limited area imaging	<1%	605	$280K
41899	Unlisted procedure, dentoalveolar structures	<1%	442	$278K
96367		<1%	3,963	$245K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,317	$243K
93971		<1%	4,127	$237K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,792	$233K
84484		<1%	89,660	$229K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,121	$221K
71046	Radiologic examination, chest; 2 views	<1%	24,119	$221K
93017		<1%	3,071	$209K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,989	$203K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,601	$203K
71250		<1%	2,820	$203K
96415		<1%	1,169	$198K
76642		<1%	1,941	$198K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	4,717	$195K
72131		<1%	4,326	$195K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,445	$192K
12001		<1%	1,419	$191K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	922	$190K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	6,018	$184K
64400		<1%	693	$183K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	2,416	$182K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	259	$182K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,337	$173K
64721		<1%	378	$172K
97162		<1%	6,747	$169K
36430		<1%	1,354	$167K
71270		<1%	787	$158K
76813		<1%	2,348	$155K
93458		<1%	196	$150K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	958	$148K
30520		<1%	160	$147K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	110,896	$146K
70487		<1%	564	$141K
97116		<1%	6,300	$139K
10060		<1%	952	$138K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	593	$137K
97166		<1%	4,695	$136K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	1,019	$136K
97602		<1%	1,070	$129K
72125	Computed tomography, cervical spine; without contrast material	<1%	10,059	$122K
72141		<1%	876	$121K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	5,215	$120K
95811		<1%	205	$120K
86850		<1%	7,301	$116K
97535	Self-care/home management training, each 15 minutes	<1%	6,428	$112K
97161		<1%	3,160	$110K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	10,194	$110K
76536		<1%	1,100	$110K
95819		<1%	845	$108K
95886		<1%	467	$105K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	85,939	$104K
71271		<1%	748	$101K
71045	Radiologic examination, chest; single view	<1%	68,582	$100K
80053	Comprehensive metabolic panel	<1%	58,076	$97K
94060		<1%	759	$95K
74178		<1%	1,237	$94K
70486		<1%	3,282	$94K
73221		<1%	511	$92K
12002		<1%	661	$84K
76775		<1%	1,331	$83K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	215,196	$83K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	536	$81K
27130		<1%	17	$78K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	927	$78K
72100		<1%	2,093	$77K
19083		<1%	116	$76K
93308		<1%	381	$76K
80320		<1%	9,844	$75K
30140		<1%	180	$75K
86900		<1%	8,076	$75K
88307		<1%	1,168	$73K
74183		<1%	385	$72K
12011		<1%	583	$71K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	91,832	$71K
93976		<1%	505	$65K
J0897	Injection, denosumab, 1 mg	<1%	51	$64K
93925		<1%	741	$64K
74018		<1%	2,330	$63K
85027		<1%	22,902	$62K
97035		<1%	1,250	$61K
88341		<1%	2,580	$60K
73700		<1%	573	$60K
J3490	Unclassified drugs	<1%	32,547	$57K
73630		<1%	6,237	$57K
72156		<1%	520	$57K
73030		<1%	5,012	$57K
J3032	Injection, eptinezumab-jjmr, 1 mg	<1%	36	$57K
78264		<1%	295	$55K
73560		<1%	3,756	$53K
72128		<1%	2,533	$52K
75635		<1%	276	$51K
90715		<1%	3,619	$51K
80076		<1%	8,009	$51K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,009	$50K
72040		<1%	1,137	$49K
58558		<1%	34	$49K
15271		<1%	64	$48K
70544		<1%	358	$48K
J1756	Injection, iron sucrose, 1 mg	<1%	2,810	$48K
10061		<1%	315	$47K
76870		<1%	889	$45K
94729		<1%	792	$45K
97163		<1%	2,700	$45K
72158		<1%	379	$44K
73130		<1%	5,931	$44K
97167		<1%	1,683	$43K
94726		<1%	684	$43K
72110		<1%	745	$42K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	936	$42K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,307	$41K
93880		<1%	644	$41K
0001A		<1%	1,293	$40K
49083		<1%	174	$39K
36415	Collection of venous blood by venipuncture	<1%	155,669	$38K
73562		<1%	3,941	$37K
96375	Therapeutic injection; each additional sequential IV push	<1%	65,504	$37K
76770		<1%	291	$36K
58571		<1%	31	$36K
96376		<1%	22,121	$36K
97165		<1%	689	$35K
93325		<1%	600	$35K
77080		<1%	688	$35K
0002A		<1%	1,006	$35K
64483		<1%	168	$34K
94660		<1%	358	$34K
76882		<1%	396	$34K
73610		<1%	4,990	$33K
73502		<1%	2,607	$31K
76641		<1%	184	$30K
D1351	Sealant - per tooth	<1%	1,422	$30K
77065	Tomosynthesis, mammo	<1%	1,130	$29K
52356		<1%	27	$28K
97113		<1%	458	$27K
36561		<1%	44	$26K
78227		<1%	102	$26K
74420		<1%	334	$26K
70498		<1%	2,812	$26K
S9472	Cardiac rehabilitation program, non-physician provider, per diem	<1%	734	$26K
76820		<1%	822	$25K
44970		<1%	18	$25K
73110		<1%	3,314	$23K
77066	Tomosynthesis, mammo	<1%	1,129	$23K
20680		<1%	35	$22K
97802		<1%	257	$22K
97597		<1%	294	$21K
86923		<1%	1,248	$21K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	18	$21K
78582		<1%	59	$20K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	1,683	$20K
83735		<1%	15,468	$20K
80069		<1%	3,502	$20K
72192		<1%	737	$20K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	25,282	$18K
88360		<1%	627	$18K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	14	$18K
J2800	Injection, methocarbamol, up to 10 ml	<1%	5,928	$18K
0240U		<1%	185	$18K
81003		<1%	74,965	$18K
85610		<1%	16,036	$17K
97012		<1%	747	$17K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,960	$17K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,511	$17K
72050		<1%	265	$16K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	40	$16K
80061	Lipid panel	<1%	3,418	$16K
81001		<1%	38,585	$15K
36569		<1%	63	$15K
82248		<1%	46,525	$14K
J2805	Injection, sincalide, 5 micrograms	<1%	119	$14K
84443	Thyroid stimulating hormone (TSH)	<1%	5,227	$14K
82565		<1%	2,237	$13K
01922		<1%	134	$13K
86920		<1%	798	$13K
72146		<1%	156	$12K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	18	$12K
87070		<1%	3,999	$12K
87086	Culture, bacterial; quantitative colony count, urine	<1%	15,735	$12K
72072		<1%	331	$12K
73590		<1%	2,277	$12K
81025		<1%	64,291	$11K
J1170	Injection, hydromorphone, up to 4 mg	<1%	15,824	$11K
72070		<1%	267	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,333	$11K
74230		<1%	133	$10K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,915	$10K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	55	$10K
36591		<1%	972	$10K
92610		<1%	600	$9K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	42	$9K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	47	$9K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	75	$9K
J2997	Injection, alteplase recombinant, 1 mg	<1%	21	$8K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	6,786	$8K
93225		<1%	64	$8K
97803		<1%	102	$8K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	18,186	$8K
72197		<1%	49	$8K
C5271	Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area	<1%	21	$8K
72157		<1%	103	$8K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,743	$8K
87040		<1%	6,542	$7K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	21	$7K
76819	Fetal biophysical profile; without non-stress testing	<1%	118	$7K
86901		<1%	8,088	$7K
J1815	Injection, insulin, per 5 units	<1%	9,529	$7K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,065	$7K
83880		<1%	7,616	$7K
71275	Computed tomographic angiography, chest, with contrast material	<1%	56	$7K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	5,495	$7K
96368		<1%	1,086	$7K
84439		<1%	2,427	$7K
J1953	Injection, levetiracetam, 10 mg	<1%	889	$6K
73552		<1%	1,308	$6K
90686		<1%	367	$6K
75574		<1%	16	$6K
92526		<1%	155	$6K
73070		<1%	1,490	$6K
85379		<1%	9,247	$6K
85730		<1%	11,021	$6K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,511	$6K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	66,284	$6K
G0008	Administration of influenza virus vaccine	<1%	542	$6K
85014		<1%	3,056	$6K
J7030	Infusion, normal saline solution , 1000 cc	<1%	48,055	$5K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,693	$5K
84702		<1%	5,191	$5K
84100		<1%	5,360	$5K
71100		<1%	422	$5K
83605		<1%	9,929	$5K
83690		<1%	41,202	$5K
72170		<1%	2,206	$5K
72114		<1%	82	$5K
76937		<1%	416	$5K
J9045	Injection, carboplatin, 50 mg	<1%	377	$5K
93922		<1%	74	$5K
95806		<1%	33	$4K
94667		<1%	230	$4K
73060		<1%	942	$4K
87088		<1%	10,418	$4K
73140		<1%	801	$4K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	384	$4K
00731		<1%	1,462	$4K
97014		<1%	115	$4K
86140		<1%	1,770	$4K
C9113	Injection, pantoprazole sodium, per vial	<1%	3,615	$4K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	406	$4K
73620		<1%	155	$4K
82803		<1%	8,205	$4K
82728		<1%	1,092	$4K
87077		<1%	4,890	$4K
73080		<1%	411	$3K
87430		<1%	6,479	$3K
82607		<1%	1,084	$3K
73090		<1%	1,428	$3K
78306		<1%	19	$3K
87641		<1%	344	$3K
93923		<1%	34	$3K
82550		<1%	4,679	$3K
84145		<1%	1,422	$3K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	484	$3K
82140		<1%	1,661	$3K
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	<1%	211	$3K
J8501	Aprepitant, oral, 5 mg	<1%	157	$3K
85018		<1%	3,100	$3K
93312		<1%	19	$3K
88365		<1%	186	$3K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,374	$3K
83540		<1%	1,403	$3K
74160		<1%	15	$3K
95700		<1%	28	$3K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,641	$2K
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	220	$2K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	966	$2K
94668		<1%	32	$2K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	28	$2K
83550		<1%	1,308	$2K
86592		<1%	676	$2K
74019		<1%	79	$2K
87186		<1%	4,573	$2K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,932	$2K
82746		<1%	934	$2K
73522		<1%	65	$2K
73600		<1%	126	$2K
86870		<1%	82	$2K
87147		<1%	1,749	$2K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,254	$2K
29581		<1%	23	$2K
76604		<1%	30	$2K
92523		<1%	52	$2K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	7,808	$2K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	2,391	$2K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,396	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	20,911	$2K
00140		<1%	1,012	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,167	$2K
20553		<1%	21	$2K
00300		<1%	728	$2K
93321		<1%	104	$2K
29125		<1%	784	$2K
86922		<1%	116	$1K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	19	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,744	$1K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	477	$1K
80164		<1%	652	$1K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	271	$1K
J2704	Injection, propofol, 10 mg	<1%	24,722	$1K
97750		<1%	55	$1K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	30,975	$1K
00160		<1%	314	$1K
99404		<1%	15	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,272	$1K
0012A		<1%	40	$1K
0011A		<1%	68	$1K
20552		<1%	38	$1K
74174		<1%	21	$1K
82330		<1%	1,018	$1K
92611		<1%	38	$1K
90714		<1%	41	$1K
00537		<1%	18	$1K
80143		<1%	2,600	$1K
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	734	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,582	$1K
36600		<1%	126	$1K
85652		<1%	2,027	$1K
82977		<1%	852	$943.75
J3535	Drug administered through a metered dose inhaler	<1%	2,158	$915.72
88331		<1%	33	$904.46
87563		<1%	1,172	$888.62
85049		<1%	1,292	$879.60
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	197	$859.70
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	5,496	$838.69
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	52,436	$831.86
84132		<1%	834	$831.23
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	12,836	$807.78
76857		<1%	34	$803.09
82570		<1%	914	$798.50
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,428	$780.95
82010		<1%	1,734	$778.15
83615		<1%	494	$758.31
J0780	Injection, prochlorperazine, up to 10 mg	<1%	4,788	$737.46
72220		<1%	47	$730.29
73000		<1%	79	$725.60
84134		<1%	66	$718.92
70250		<1%	52	$708.30
87905		<1%	1,293	$700.67
J1790	Injection, droperidol, up to 5 mg	<1%	3,669	$626.52
0003A		<1%	15	$613.40
84703		<1%	1,400	$612.58
73100		<1%	40	$603.06
87449		<1%	612	$601.88
97022		<1%	21	$596.18
86308		<1%	439	$591.94
71101		<1%	162	$586.97
86803		<1%	330	$586.78
J2060	Injection, lorazepam, 2 mg	<1%	4,115	$572.28
73120		<1%	20	$565.12
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	4,065	$559.38
J1940	Injection, furosemide, up to 20 mg	<1%	2,268	$553.23
J3360	Injection, diazepam, up to 5 mg	<1%	1,689	$549.12
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	10,408	$518.53
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	20,494	$513.37
84156		<1%	900	$506.00
00400		<1%	951	$499.41
72082		<1%	12	$490.48
77002		<1%	12	$486.72
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	686	$475.76
80074		<1%	117	$469.90
87340		<1%	254	$468.36
29515		<1%	50	$441.46
77001		<1%	75	$439.82
85347		<1%	481	$432.58
80179		<1%	2,490	$417.82
36416		<1%	3,435	$397.38
87081		<1%	344	$394.45
87205		<1%	867	$393.17
00940		<1%	157	$378.44
85045		<1%	1,176	$351.54
80177		<1%	319	$342.29
76000		<1%	19	$327.78
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,478	$309.17
88342		<1%	2,937	$302.73
J7999	Compounded drug, not otherwise classified	<1%	520	$286.57
90656		<1%	43	$280.90
82040		<1%	81	$263.30
81015		<1%	709	$257.27
J3480	Injection, potassium chloride, per 2 meq	<1%	3,260	$257.13
87481		<1%	133	$256.54
51702		<1%	166	$251.67
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	956	$247.40
87529		<1%	342	$239.96
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,959	$238.29
C1889	Implantable/insertable device, not otherwise classified	<1%	605	$231.46
00840		<1%	1,288	$230.51
70360		<1%	20	$218.72
88304		<1%	1,708	$168.03
87075		<1%	473	$165.67
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	816	$157.82
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,592	$153.79
87486		<1%	20	$146.15
84295		<1%	83	$143.19
97763		<1%	127	$136.58
J3410	Injection, hydroxyzine hcl, up to 25 mg	<1%	265	$134.19
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	33,524	$123.46
J0280	Injection, aminophyllin, up to 250 mg	<1%	18	$115.25
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	122	$106.42
J1630	Injection, haloperidol, up to 5 mg	<1%	1,064	$105.38
82784		<1%	44	$102.26
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	718	$97.76
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,815	$95.79
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	4,088	$87.75
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	993	$87.46
87324		<1%	46	$87.02
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	846	$80.91
0031A		<1%	26	$79.19
87653		<1%	31	$78.87
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	1,742	$78.83
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	15,552	$76.13
87581		<1%	20	$73.06
J0456	Injection, azithromycin, 500 mg	<1%	749	$72.98
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,371	$72.30
86304		<1%	29	$69.04
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	256	$54.94
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,794	$53.21
90694		<1%	23	$52.92
84550		<1%	115	$48.11
J1956	Injection, levofloxacin, 250 mg	<1%	243	$47.44
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	5,398	$40.19
J1171	Injection, hydromorphone, 0.1 mg	<1%	611	$36.39
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	376	$36.11
80305		<1%	134	$34.44
89051		<1%	306	$34.04
84436		<1%	36	$30.87
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	71	$29.88
83930		<1%	56	$27.30
J1836	Injection, metronidazole, 10 mg	<1%	106	$27.11
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	985	$26.75
85651		<1%	42	$24.78
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	1,750	$24.38
J9267	Injection, paclitaxel, 1 mg	<1%	265	$23.79
J8540	Dexamethasone, oral, 0.25 mg	<1%	179	$23.28
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	1,271	$22.53
91300		<1%	2,164	$19.36
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	668	$18.47
C1762	Connective tissue, human (includes fascia lata)	<1%	15	$17.74
Q4102	Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)	<1%	106	$17.00
95909		<1%	15	$13.23
J2470	Injection, pantoprazole sodium, 40 mg	<1%	335	$12.93
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	3,097	$12.60
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	49	$10.26
J7050	Infusion, normal saline solution, 250 cc	<1%	11,478	$5.20
J8597	Antiemetic drug, oral, not otherwise specified	<1%	337	$2.12
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	18	$1.20
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	193	$0.80
91301		<1%	95	$0.74
91303		<1%	26	$0.02
J2785	Injection, regadenoson, 0.1 mg	0%	2,299	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	70	$0.00
00790		0%	691	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	233	$0.00
C1781	Mesh (implantable)	0%	451	$0.00
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	0%	248	$0.00
A9270	Non-covered item or service	0%	1,091	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	155	$0.00
00813		0%	169	$0.00
88377		0%	99	$0.00
85576		0%	53	$0.00
C1769	Guide wire	0%	2,128	$0.00
00952		0%	192	$0.00
94761		0%	259	$0.00
A4648	Tissue marker, implantable, any type, each	0%	461	$0.00
00142		0%	918	$0.00
01480		0%	287	$0.00
00902		0%	41	$0.00
J0697	Injection, sterile cefuroxime sodium, per 750 mg	0%	303	$0.00
88364		0%	21	$0.00
80178		0%	24	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	62	$0.00
94760		0%	16	$0.00
00320		0%	36	$0.00
0051A		0%	40	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	90	$0.00
01214		0%	17	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	162	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	17	$0.00
84157		0%	19	$0.00
96411		0%	114	$0.00
94762		0%	68	$0.00
91305		0%	37	$0.00
82945		0%	19	$0.00
93356		0%	1,073	$0.00
15853		0%	242	$0.00
C1776	Joint device (implantable)	0%	657	$0.00
00918		0%	138	$0.00
01810		0%	809	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	343	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	770	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	628	$0.00
01965		0%	43	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	177	$0.00
96417		0%	1,508	$0.00
01830		0%	175	$0.00
Q9956	Injection, octafluoropropane microspheres, per ml	0%	951	$0.00
88302		0%	239	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	29	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	738	$0.00
82365		0%	48	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	170	$0.00
S0596	Phakic intraocular lens for correction of refractive error	0%	525	$0.00
99408		0%	230	$0.00
00910		0%	180	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	50	$0.00
C1875	Stent, coated/covered, without delivery system	0%	12	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	326	$0.00
00811		0%	116	$0.00
88112		0%	30	$0.00
94150		0%	37	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	73	$0.00
C1729	Catheter, drainage	0%	25	$0.00
88173		0%	29	$0.00
C1758	Catheter, ureteral	0%	13	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	45	$0.00
69209		0%	43	$0.00
88313		0%	18	$0.00
C1788	Port, indwelling (implantable)	0%	45	$0.00
77012		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGANGER, CRAIG (SYSTEM VP/CHIEF FINANCIAL OFFICER)